1.
Zerga M. New therapeutic options for relapsed/refractory diffuse large b-cell lymphoma. Treatment with tafasitamab + lenalidomide. RH [Internet]. 2026 Jan. 30 [cited 2026 Nov. 18];29(3):61-70. Available from: https://mail.revistahematologia.com.ar/index.php/Revista/article/view/687